Literature DB >> 30658034

Assessment of Topical Therapies for Improving the Optical Clarity Following Stromal Wounding in a Novel Ex Vivo Canine Cornea Model.

William M Berkowski1, Daniel J Gibson2, SooJung Seo2, Laura R Proietto1, R David Whitley1, Gregory S Schultz2, Caryn E Plummer1.   

Abstract

Purpose: To evaluate the effect of topical suberanilohydroxamic acid (SAHA) and 5-methyl-1-phenyl-2[1H]-pyridone (pirfenidone) on the degree of corneal haze in the stromal wounded ex vivo canine cornea.
Methods: Twenty-four corneoscleral rims from normal dogs were uniformly wounded with an excimer laser and placed into culture medium with an air-liquid interface. The control group (n = 8) contained placebo-treated corneas. Treatment group 1 (n = 8) received SAHA topically every 6 hours. Treatment group 2 (n = 8) received pirfenidone topically every 6 hours. Each cornea was fluorescein stained and macrophotographed every 6 hours to assess epithelialization rate. All corneas were also macrophotographed weekly to assess optical clarity (haze). Images were analyzed for differences in pixel intensity between wounded (haze) and unwounded (nonhaze) regions, and haze surface area for each cornea was calculated.
Results: The mean epithelialization time was 47.25 hours in the control group, 45.00 hours in the SAHA group, and 43.50 hours in the pirfenidone group, revealing no significant difference (P = 0.368). The median difference in pixel intensity between haze and nonhaze areas was 21.5 in the control group, 8.0 in the SAHA group, and 8.0 in the pirfenidone group, which is significant (P < 0.01). The median haze surface area was 12.96 mm2 in the control group, 5.70 mm2 in the SAHA group, and 5.92 mm2 in the pirfenidone group, which is significant (P < 0.01). Conclusions: Stromal-wounded ex vivo canine corneas exhibited greater optical clarity when treated with SAHA and pirfenidone than when placebo treated at 21 days. There was no significant difference in epithelialization rate between groups. Corneal contour was correlated with geographic haze distribution.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30658034     DOI: 10.1167/iovs.17-23085

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  3 in total

1.  An ex vivo cornea infection model.

Authors:  Uloma Ubani-Ukoma; Anuj Chauhan; Gregory Schultz; Daniel J Gibson
Journal:  MethodsX       Date:  2020-04-07

2.  Evaluation of a novel combination of TRAM-34 and ascorbic acid for the treatment of corneal fibrosis in vivo.

Authors:  Allison A Fuchs; Praveen K Balne; Elizabeth A Giuliano; Nishant R Sinha; Rajiv R Mohan
Journal:  PLoS One       Date:  2022-01-10       Impact factor: 3.240

3.  Assessment of Cidofovir for Treatment of Ocular Bovine Herpesvirus-1 Infection in Cattle Using an Ex-Vivo Model.

Authors:  Christopher R Alling; Chin-Chi Liu; Ingeborg M Langohr; Muzammel Haque; Renee T Carter; Rose E Baker; Andrew C Lewin
Journal:  Viruses       Date:  2021-10-18       Impact factor: 5.048

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.